Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Inefficient vascular supply and the resultant reduction in tissue oxygen tension often lead to neovascularization in order to satisfy the needs of the tissue. Examples include the compensatory development of collateral blood vessels in ischaemic tissues that are otherwise quiescent for angiogenesis and angiogenesis associated with the healing of hypoxic wounds. But the presumptive hypoxia-induced angiogenic factors that mediate this feedback response have not been identified. Here we show that vascular endothelial growth factor (VEGF; also known as vascular permeability factor) probably functions as a hypoxia-inducible angiogenic factor. VEGF messenger RNA levels are dramatically increased within a few hours of exposing different cell cultures to hypoxia and return to background when normal oxygen supply is resumed. In situ analysis of tumour specimens undergoing neovascularization show that the production of VEGF is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci (presumably hypoxic regions) and the clustering of capillaries alongside VEGF-producing cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cells grown under hypoxic conditions activate transcription of vascular endothelial growth factor (VEGF) (Shweiki et al., 1992;Forsythe et al., 1996), which is important for endothelial cell activation and proliferation.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Shweiki et al., 1992
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Differentiated Rat Glial Cell Strain in Tissue Culture
Benda, P., Lightbody, J., Sato, G., Levine, L., & Sweet, W. (1968) · Science · doi:10.1126/science.161.3839.370 · Cited by 1,472
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Research works printed but not linked: 2
- Adair, T. A., Gay, W. J. & Montani, J.-P. Am. J. Physiol. 259, R393–R404 (1990).
- Knighton, D., Schumerth, S. & Fiegel, V. in Current Communications in Molecular Biology (eds Rifkin, D. B. & Klagsbrun, M.) 150–154 (Cold Spring Harbor Laboratory Press, New York, 1987).
Cited by
Items 1,001–1,033 of 1,033
Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis
Lee, S.-J., Kim, H.-P., Jin, Y., Choi, A. M. K., & Ryter, S. W. (2011) · Autophagy · doi:10.4161/auto.7.8.15598 · Cited by 129
Multiple burr-hole operation for adult moyamoya disease
Kawaguchi, T., Fujita, S., Hosoda, K., Shose, Y., Hamano, S., Iwakura, M., & Tamaki, N. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.84.3.0468 · Cited by 130
Candidate genes for the hypoxic tumor phenotype.
Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L. M., Koch, C., Evans, S. M., Ibrahim, H., Le, Q., Terris, D. J., et al. (2000) · PubMed · Cited by 239
Laitinen, M., Ristimäki, A., Honkasalo, M., Narko, K., Paavonen, K., & Ritvos, O. (1997) · Endocrinology · doi:10.1210/en.138.11.4748 · Cited by 130
Makino, Y., Uenishi, R., Okamoto, K., Isoe, T., Hosono, O., Tanaka, H., Kanopka, A., Poellinger, L., Haneda, M., & Morimoto, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700732200 · Cited by 120
Sleep apnea and subsequent cancer incidence
Sillah, A., Watson, N. F., Schwartz, S. M., Gozal, D., & Phipps, A. I. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1073-5 · Cited by 113
Machein, Kullmer, Rönicke, Machein, Krieg, Damert, Breier, Risau, & Plate (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00166.x · Cited by 113
VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
Cao, Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.114 · Cited by 109
A tissue injury sensing and repair pathway distinct from host pathogen defense
Liu, S., Hur, Y. H., Cai, X., Cong, Q., Yang, Y., Xu, C., Bilate, A. M., Gonzales, K. A. U., Parigi, S. M., Cowley, C. J., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.031 · Cited by 108
Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
Schoppmann, S. F., Fenzl, A., Schindl, M., Bachleitner-Hofmann, T., Nagy, K., Gnant, M., Horvat, R., Jakesz, R., & Birner, P. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9190-3 · Cited by 106
“One of the best characterized HIF-1a regulated targets is the vascular endothelial growth factor (VEGF) gene, which encodes a factor of main importance for blood vessel growth and maintenance [4,5].”
BackgroundMechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells
Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., & Ibrahim, S. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301373200 · Cited by 104
Can VEGF reverse diabetic neuropathy in human subjects?
Veves, A., & King, G. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13038 · Cited by 88
Schobersberger, W., Hobisch-Hagen, P., Fries, D., Wiedermann, F., Rieder-Scharinger, J., Villiger, B., Frey, W., Herold, M., Fuchs, D., & Jelkmann, W. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80078-9 · Cited by 83
The Oxygen Paradox, the French Paradox, and age-related diseases
Davies, J. M. S., Cillard, J., Friguet, B., Cadenas, E., Cadet, J., Cayce, R., Fishmann, A., Liao, D., Bulteau, A.-L., Derbré, F., et al. (2017) · GeroScience · doi:10.1007/s11357-017-0002-y · Cited by 82
Reshetnikova, O. S., Burton, G. J., Milovanov, A. P., & Fokin, E. I. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70427-1 · Cited by 77
Blood Flow Restricted Exercise and Vascular Function
Horiuchi, M., & Okita, K. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/543218 · Cited by 75
Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues
Li, Y., Jiang, C., Wang, X., Zhang, Y., Shibahara, S., & Takahashi, K. (2007) · Peptides · doi:10.1016/j.peptides.2007.03.005 · Cited by 71
Sun, J., Hopkins, B. D., Tsujikawa, K., Perruzzi, C., Adini, I., Swerlick, R., Bornstein, P., Lawler, J., & Benjamin, L. E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01246.2008 · Cited by 56
Small molecules targeting HIF-1α pathway for cancer therapy in recent years.
Tang, W., & Zhao, G. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115235 · Cited by 50
Chiarotto, J. A., & Hill, R. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690555 · Cited by 46
Pericytes: Problems and Promises for CNS Repair
Laredo, F., Plebanski, J., & Tedeschi, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00546 · Cited by 44
Tower, R. J., Busse, E., Jaramillo, J., Lacey, M., Hoffseth, K., Guntur, A. R., Simkin, J., & Sammarco, M. C. (2022) · eLife · doi:10.7554/elife.71542 · Cited by 43
Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix
Ortéga, N., L'Faqihi, F., & Plouët, J. (1998) · Biology of the Cell · doi:10.1111/j.1768-322x.1998.tb01047.x · Cited by 42
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010)
Ban, H. S., Uto, Y., & Nakamura, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.547477 · Cited by 42
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
Ria, R., Melaccio, A., Racanelli, V., & Vacca, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061765 · Cited by 40
“Some metabolic factors, such as hypoxia and hypoglycemia, regulate the production and release of VEGF-A [78].”
BackgroundMeyuhas, R., Pikarsky, E., Tavor, E., Klar, A., Abramovitch, R., Hochman, J., Lago, T. G., & Honigman, A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2086 · Cited by 39
“growth factor, VEGF, platelet-derived growth factor, interleukin-8, angiogenin, and CCN1, is enhanced in response to hypoxia (10, 14-22).”
BackgroundThe Influence of Glucose Concentration and Hypoxia on VEGF Secretion by Cultured Retinal Cells
Kennedy, A., & Frank, R. N. (2011) · Current Eye Research · doi:10.3109/02713683.2010.521968 · Cited by 38
Ping, W., Sun, W., Zu, Y., Chen, W., & Fu, X. (2014) · Tumor Biology · doi:10.1007/s13277-013-1579-0 · Cited by 36
Feng, Y., Rhodes, P. G., Liu, H., & Bhatt, A. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.024 · Cited by 29
HIF-1 is Essential for Multilineage Hematopoiesis in the Embryo
Adelman, D. M., Maltepe, E., & Simon, M. C. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-46825-5_26 · Cited by 25
“We have previously shown that mice die in utero between E9.5 and E10.5 due to inadequate VEGF expression and subsequent vascular defects (Maltepe et al. 1997), suggesting that hypoxia-induced VEGF production, which is important for tumor angiogenesis ( Shweiki et al. 1992 ), also regulates developmental angiogenesis.”
BackgroundZhang, Y., Zhao, X., Guo, C., Zhang, Y., Zeng, F., Yin, Q., Li, Z., Shao, L., Zhou, D., & Liu, L. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01042-9 · Cited by 25
Coordinated Expression of Ets-1, pERK1/2, and VEGF in Retina of Streptozotocin-Induced Diabetic Rats
Du, Z.-J., Kamei, M., Suzuki, M., Tano, Y., Wang, B.-R., & Hui, Y.-N. (2007) · Ophthalmic Research · doi:10.1159/000104831 · Cited by 12
“Therefore, extrapolating these studies and our results, we propose that VEGF, Ets-1, and ERK1/2 may act synergistically in the pathological development of diabetic retinopathy with the involvement of both Flt-1 and Flk-1. Our postulation can be summarized as follows (fig. 4 ). First, STZ-induced hyperglycemia results…”
ResultNomura, T., Yamakawa, M., Shimaoka, T., Hirai, T., Koizumi, N., Maruyama, K., & Utoguchi, N. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00737 · Cited by 6
Metadata
- Authors
- Shweiki, D., Itin, A., Soffer, D., & Keshet, E.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- Nature
- Published
- 1992-10
- Volume
- 359
- Issue
- 6398
- Pages
- 843-845
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015344488
- Cited by
- 4,617
- References
- 28
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 70 · 2023: 70 · 2022: 89 · 2021: 90 · 2020: 94 · 2019: 98 · 2018: 81 · 2017: 83 · 2016: 114 · 2015: 104 · 2014: 128 · 2013: 137 · 2012: 141
- FWCI
- 29.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, hypoxia, angiogenesis, neovascularization, glioblastoma, tumor necrosis, tumor hypoxia, tumor vasculature
- MeSH terms
- Animals, Brain Neoplasms, Cell Division, Endothelium, Vascular, Glioblastoma, Humans, Lymphokines, Necrosis, Neovascularization, Pathologic, RNA, Messenger, RNA, Neoplasm, Tumor Cells, Cultured, Cell Hypoxia, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.